- Home
- TARA vs NCO Comparison
TARA vs NCO Comparison
Compare TARA & NCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARA | NCO |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.6M | 146.0M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | TARA | NCO |
|---|---|---|
| Price | $2.34 | $9.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $25.71 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 67.7K |
| Earning Date | 11-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $9.83 |
| 52 Week High | $7.82 | $9.96 |
Technical Indicators
Market Signals| Indicator | TARA | NCO |
|---|---|---|
| Relative Strength Index (RSI) | 29.64 | 61.86 |
| Support Level | N/A | $9.90 |
| Resistance Level | $4.13 | N/A |
| Average True Range (ATR) | 0.16 | 0.01 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 11.82 | 66.67 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About NCO Southern Cross Acquisition I Corp. Ordinary Shares
Southern Cross Acquisition I Corp is a blank check company formed for the purpose of effecting into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.